ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,455Medicare Part D Prescriptions Filled, Including Refills

Rank: 101 out of 910

$788K Total Retail Price of All Prescriptions

Rank: 44 out of 910

833 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
13% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 833 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

9% of this provider’s 833 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 9,432 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LEVOTHYROXINE SODIUM 702 659 1 1
SIMVASTATIN 650 585 2 3
LISINOPRIL 335 300 3 2
AMLODIPINE BESYLATE 270 257 4 4
ZOLPIDEM TARTRATE 243 229 5 17
POTASSIUM CHLORIDE 219 205 6 18
HYDROCHLOROTHIAZIDE 210 201 7 12
OMEPRAZOLE 208 182 8 5
METFORMIN HCL 191 169 9 6
LIOTHYRONINE SODIUM 188 187 10 170
CITALOPRAM HBR 178 161 11 19
HYDROCODONE-ACETAMINOPHEN 177 155 S3 12 8
FUROSEMIDE 176 163 13 9
METOPROLOL TARTRATE 167 162 14 7
ATENOLOL 159 141 15 10
LOSARTAN POTASSIUM 143 131 16 15
TRAMADOL HCL 143 130 16 25
FLUTICASONE PROPIONATE 134 122 18 23
ALENDRONATE SODIUM 133 123 19 22
GABAPENTIN 131 97 20 13
TRAZODONE HCL 121 100 21 37
CYMBALTA 118 99 22 58
RANITIDINE HCL 117 112 23 28
TRIAMTERENE-HCTZ 109 105 24 39
CRESTOR 106 97 25 26
METOPROLOL SUCCINATE 97 97 26 21
SERTRALINE HCL 94 88 27 24
CIPROFLOXACIN HCL 85 79 28 48
VENLAFAXINE HCL ER 83 66 29 115
OXYCODONE HCL 81 49 S2 30 42
OXYCODONE-ACETAMINOPHEN 78 76 S2 31 31
WARFARIN SODIUM 78 74 31 11
SYMBICORT 78 59 31 178
PANTOPRAZOLE SODIUM 77 66 34 27
ESCITALOPRAM OXALATE 71 70 35 113
CYCLOBENZAPRINE HCL 69 68 R 36 80
SPIRIVA 68 63 37 74
LOVASTATIN 68 67 37 20
ATORVASTATIN CALCIUM 67 62 39 14
ALLOPURINOL 66 66 40 33
SYNTHROID 66 66 40 54
DIOVAN 65 64 42 34
FLUOXETINE HCL 63 47 43 49
ADVAIR DISKUS 63 63 43 45
CLOPIDOGREL 63 61 43 35
PROAIR HFA 60 56 46 40
CELEBREX 58 52 47 85
PRAVASTATIN SODIUM 55 42 48 16
SINGULAIR 52 50 49 144
PREDNISONE 52 41 49 43
PROPRANOLOL HCL 51 39 51 120
VESICARE 50 49 52 210
MONTELUKAST SODIUM 50 39 52 239
GLYBURIDE 50 38 R 52 46
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 20, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.